MLOAX | VENAX | MLOAX / VENAX | |
Total Expense Ratio | 1.25 | 0.09 | 1,389% |
Annual Report Gross Expense Ratio | 1.65 | 0.09 | 1,833% |
Fund Existence | 12 years | 21 years | - |
Gain YTD | 5.705 | 0.921 | 619% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 8.11B | 1% |
Annual Yield % from dividends | 4.58 | 3.27 | 140% |
Returns for 1 year | 7.31 | -4.70 | -155% |
Returns for 3 years | 38.20 | 21.52 | 178% |
Returns for 5 years | 136.14 | 146.87 | 93% |
Returns for 10 years | 37.55 | 17.86 | 210% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCLLX | 16.98 | 0.16 | +0.95% |
Goldman Sachs Enhanced U.S. Equity C | |||
ICPUX | 6.38 | 0.06 | +0.95% |
Integrity Mid-North American Resources C | |||
VITSX | 150.04 | 1.28 | +0.86% |
Vanguard Total Stock Market Idx I | |||
PARWX | 56.17 | 0.32 | +0.57% |
Parnassus Value Equity Investor | |||
JGYIX | 13.02 | 0.06 | +0.46% |
JHancock Global Shareholder Yield I |